Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
Background Although potential therapeutic candidates for heart failure with preserved ejection fraction (HFpEF) are emerging, it is still unclear whether they will be effective in patients with left ventricular ejection fraction (LVEF) of 60% or higher. Our aim was to identify the clinical character...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wiley
2022-08-01
|
| Rangatū: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Ngā marau: | |
| Urunga tuihono: | https://www.ahajournals.org/doi/10.1161/JAHA.122.025300 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
